Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apellis Pharmaceuticals (APLS) Interest Coverage Ratio (2020 - 2025)

Historic Interest Coverage Ratio for Apellis Pharmaceuticals (APLS) over the last 6 years, with Q3 2025 value amounting to 19.79.

  • Apellis Pharmaceuticals' Interest Coverage Ratio rose 62448.54% to 19.79 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.79, marking a year-over-year increase of 12900.11%. This contributed to the annual value of 4.08 for FY2024, which is 7663.51% up from last year.
  • Latest data reveals that Apellis Pharmaceuticals reported Interest Coverage Ratio of 19.79 as of Q3 2025, which was up 62448.54% from 2.98 recorded in Q2 2025.
  • Over the past 5 years, Apellis Pharmaceuticals' Interest Coverage Ratio peaked at 19.79 during Q3 2025, and registered a low of 56.09 during Q3 2021.
  • Moreover, its 5-year median value for Interest Coverage Ratio was 16.41 (2023), whereas its average is 16.79.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first crashed by 31878.48% in 2021, then soared by 62448.54% in 2025.
  • Quarter analysis of 5 years shows Apellis Pharmaceuticals' Interest Coverage Ratio stood at 29.62 in 2021, then increased by 28.43% to 21.2 in 2022, then soared by 46.14% to 11.42 in 2023, then skyrocketed by 80.13% to 2.27 in 2024, then skyrocketed by 972.3% to 19.79 in 2025.
  • Its last three reported values are 19.79 in Q3 2025, 2.98 for Q2 2025, and 7.54 during Q1 2025.